Literature DB >> 18563429

Prompt therapy reduces the duration of systemic corticosteroids in Vogt-Koyanagi-Harada disease.

Nobuyoshi Kitaichi, Yukihiro Horie, Shigeaki Ohno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18563429     DOI： 10.1007/s00417-008-0869-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  The positive role of lumbar puncture in the diagnosis of Vogt-Koyanagi-Harada disease: lymphocyte subsets in the aqueous humor and cerebrospinal fluid.

Authors:  Nobuyoshi Kitaichi; Hiroko Matoba; Shigeaki Ohno
Journal:  Int Ophthalmol       Date:  2007-01-09       Impact factor: 2.031

2.  Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada's disease.

Authors:  Mizuki Kitamura; Kimitaka Takami; Nobuyoshi Kitaichi; Nobuyoshi Kitachi; Kenichi Namba; Hirokuni Kitamei; Satoshi Kotake; Shigeaki Ohno
Journal:  Am J Ophthalmol       Date:  2005-06       Impact factor: 5.258

3.  Vogt-Koyanagi-Harada syndrome.

Authors:  S Ohno; D H Char; S J Kimura; G R O'Connor
Journal:  Am J Ophthalmol       Date:  1977-05       Impact factor: 5.258

4.  Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease.

Authors:  A Jap; C D Luu; I Yeo; S-P Chee
Journal:  Eye (Lond)       Date:  2006-09-15       Impact factor: 3.775

5.  Epidemiological survey of intraocular inflammation in Japan.

Authors:  Hiroshi Goto; Manabu Mochizuki; Kunihiko Yamaki; Satoshi Kotake; Masahiko Usui; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2007-02-09       Impact factor: 2.447
  5 in total
  5 in total

1.  Evaluation of NLRP1 gene polymorphisms in Vogt-Koyanagi-Harada disease.

Authors:  Yukihiro Horie; Wataru Saito; Nobuyoshi Kitaichi; Toshie Miura; Susumu Ishida; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

2.  Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease.

Authors:  Kiriko Hirooka; Wataru Saito; Kenichi Namba; Yuko Takemoto; Kazuomi Mizuuchi; Tomoe Uno; Yoshiaki Tagawa; Yuki Hashimoto; Susumu Ishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-27       Impact factor: 3.117

3.  Outcomes of patients with acute Vogt-Koyanagi-Harada disease treated with intravenous corticosteroid pulse followed by the slow tapering of oral corticosteroid therapy.

Authors:  Rui Fushitsu; Akihiro Ishibazawa; Masataka Murono; Reiko Kinouchi
Journal:  Int Ophthalmol       Date:  2022-07-22       Impact factor: 2.029

4.  Treatment and Prognosis of Vogt-Koyanagi-Harada Disease: Real-Life Experience in Long-Term Follow-Up.

Authors:  Massimo Accorinti; Maria Carmela Saturno; Ludovico Iannetti; Priscilla Manni; Davide Mastromarino; Maria Pia Pirraglia
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

Review 5.  miRNA Landscape in Pathogenesis and Treatment of Vogt-Koyanagi-Harada Disease.

Authors:  Fabian Vega-Tapia; Mario Bustamante; Rodrigo A Valenzuela; Cristhian A Urzua; Loreto Cuitino
Journal:  Front Cell Dev Biol       Date:  2021-05-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.